Anti-TGF-alfabeta (Transforming Growth Factor beta) Monoklonale Antilichaam (Kloon: TGF-alfa/510)

This MAb recognizes TGF-alphabeta 1, 2 and 3. TGF-alphas inhibit the growth of epithelial cells and stimulate the growth of mesenchymal cells.Most breast lesions, benign and malignant, involve abnormal proliferation and altered architecture of stromal and/or epithelial elements.

ARVD; BSC 1 cell growth inhibitor; CED; Cetermin; Diaphyseal dysplasia 1 (DPD1) ; Glioblastoma derived T cell suppressor factor (G TSF) ; Latency-associated peptide (LAP) ; Polyergin; Transforming growth factor beta 1 (TGF-alphabeta1 or TGF-alpha1) ; TGF-alphabeta2 (TGF-alpha2) ; TGF-alphabeta3 (TGF-alpha3) ; TGF-alphaeta (TGF-alpha)

TFGB

7040; 7042; 7043

P01137 ; P10600 ; P61812

Human, Mouse, Rat

Full length recombinant human TGF-alphabeta2 protein

TGF-alpha/510

Functional Assay, ELISA

200 μg/mL of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/mL.

Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous.

Functional Assay (Order Ab without BSA/Azide) ; ELISA (0.1-0.4ug/ml - Detection; 2-8ug/ml - Capture)

Mouse IgG1, kappa